Axim Biotechnologies Inc (OTCQB:AXIM)

0.45
Delayed Data
As of Dec 06
 +0.01 / +2.27%
Today’s Change
0.36
Today|||52-Week Range
2.50
-40.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Operating ActivitiesNet Income / Starting Line-1.7M-1.3M-978.9K-2.3M
 
 
 
 
 
Depreciation838.00839.00-8.6K4.0K
 
 
 
 
 
Total Other Cash Flow389.8K364.2K-58.5K1.2M
 
 
 
 
 
Funds From Operations-1.3M-968.6K-1.0M-1.2M
 
 
 
 
 
Funds From/For Other Operating Expenses369.7K59.6K-26.8K-469.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-1.7M-1.0M-1.0M-705.3K
 
 
 
 
 
 
InvestingNet Cash Flow Investing0.000.000.000.00--
 
FinancingShort Term Borrowings69.8K-23.8K-22.8K-23.3K
 
 
 
 
 
Long Term Borrowings0.000.001.8M0.00
 
 
Long Term Debt Reduction-1.0M-782.0K-1.00-7.5K
 
 
 
 
 
Net Proceeds Stock Sale2.4M1.6M433.4K1.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing7.5K400.0K0.000.00
 
 
 
Other Uses - Financing0.00----0.00--
Net Cash Flow - Financing1.4M1.1M2.2M1.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-210.4K117.1K1.2M856.8K